KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Net Margin (2016 - 2025)

Historic Net Margin for Pacira BioSciences (PCRX) over the last 16 years, with Q3 2025 value amounting to 3.03%.

  • Pacira BioSciences' Net Margin rose 881300.0% to 3.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.99%, marking a year-over-year increase of 160500.0%. This contributed to the annual value of 14.2% for FY2024, which is 204200.0% down from last year.
  • Per Pacira BioSciences' latest filing, its Net Margin stood at 3.03% for Q3 2025, which was up 881300.0% from 2.68% recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Net Margin registered a high of 15.2% during Q2 2023, and its lowest value of 85.11% during Q3 2024.
  • Its 5-year average for Net Margin is 0.48%, with a median of 5.37% in 2024.
  • As far as peak fluctuations go, Pacira BioSciences' Net Margin tumbled by -969500bps in 2021, and later skyrocketed by 881300bps in 2025.
  • Over the past 5 years, Pacira BioSciences' Net Margin (Quarter) stood at 3.22% in 2021, then tumbled by -82bps to 5.87% in 2022, then soared by 334bps to 13.72% in 2023, then plummeted by -38bps to 8.57% in 2024, then tumbled by -65bps to 3.03% in 2025.
  • Its last three reported values are 3.03% in Q3 2025, 2.68% for Q2 2025, and 2.85% during Q1 2025.